Georg Bartsch

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 100 Citations 28,960 726 World Ranking 4997 National Ranking 16

Best Publications

Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor

Zoran Culig;Alfred Hobisch;Marcus V. Cronauer;Christian Radmayr.
Cancer Research (1994)

1239 Citations

Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.

Z. Culig;A. Hobisch;M. V. Cronauer;A. C. B. Cato.
Molecular Endocrinology (1993)

583 Citations

Robotic-assisted laparoscopic partial nephrectomy: Technique and initial clinical experience with daVinci robotic system

Matthew T. Gettman;Michael L. Blute;George K. Chow;Richard Neururer.
Urology (2004)

544 Citations

Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells.

Lorenz Höltl;Claudia Zelle-Rieser;Hubert Gander;Christine Papesh.
Clinical Cancer Research (2002)

528 Citations

Interleukin-6 Regulates Prostate-specific Protein Expression in Prostate Carcinoma Cells by Activation of the Androgen Receptor

Alfred Hobisch;Iris E. Eder;Thomas Putz;Wolfgang Horninger.
Cancer Research (1998)

527 Citations

Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: The prospective european doxazosin and combination therapy (predict) trial

Roger S Kirby;Claus Roehrborn;Peter Boyle;Georg Bartsch.
Urology (2003)

485 Citations

Evaluation and management of renal injuries: consensus statement of the renal trauma subcommittee.

R A Santucci;H Wessells;G Bartsch;J Descotes.
BJUI (2004)

471 Citations

Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system

Z Culig;J Hoffmann;M Erdel;I E Eder.
British Journal of Cancer (1999)

466 Citations

Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy

C. Shad Thaxton;Robert Elghanian;Audrey D. Thomas;Savka I. Stoeva.
Proceedings of the National Academy of Sciences of the United States of America (2009)

426 Citations

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria.

Georg Bartsch;Wolfgang Horninger;Helmut Klocker;Andreas Reissigl.
Urology (2001)

422 Citations

If you think any of the details on this page are incorrect, let us know.